Detect, predict, and prevent acute seizures and status epilepticus

Tobias Loddenkemper1

  • 1Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Boston, MA 02115, USA.

Insights

Status epilepticus (SE) is a pediatric emergency. Early detection and prompt, accurate treatment are crucial for better outcomes in pediatric convulsive seizures and SE.

Area of Science:

  • Neurology
  • Pediatric Emergency Medicine

Background:

  • Status epilepticus (SE) is a common and serious neurological emergency in children.
  • While the cause of SE influences prognosis, modifiable factors like timely detection and treatment are key.
  • Delayed or inadequate treatment can prolong seizures and worsen outcomes.

Purpose of the Study:

  • To identify strategies for improving the management of pediatric acute seizures and status epilepticus.
  • To address barriers in recognizing at-risk patients and providing timely, equitable care.
  • To enhance detection, prediction, and closed-loop treatment for SE.

Main Methods:

  • Review of challenges and barriers in acute seizure and SE care.
  • Discussion of strategies for risk identification, detection, and prediction.
  • Outline of approaches for acute closed-loop treatment and SE prevention.

Main Results:

  • Identified key modifiable risk factors for poor outcomes in pediatric SE.
  • Highlighted barriers including patient/physician factors, access to treatment, and care variations.
  • Proposed strategies for improved patient identification, detection, and treatment.

Conclusions:

  • Effective management of pediatric SE requires addressing detection, treatment timing/dosing, and access barriers.
  • Proactive strategies for risk identification and improved care delivery are essential.
  • The presented strategies aim to improve outcomes for children experiencing SE.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
235
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
502
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
747
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
233
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
456
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
384